Lataa...
Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B
Since its introduction in the 1990s, liposomal amphotericin B (LAmB) continues to be an important agent for the treatment of invasive fungal diseases caused by a wide variety of yeasts and molds. This liposomal formulation was developed to improve the tolerability of intravenous amphotericin B, whil...
Tallennettuna:
| Julkaisussa: | Clin Infect Dis |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6495018/ https://ncbi.nlm.nih.gov/pubmed/31222253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz076 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|